Endocrine Market Analysis and Reports | USA Conference Series

Market Analysis - Endocrine 2017

Endocrine 2017

With the change in life style, eating habits, environment, the rate of metabolic diseases among large population is increasing rapidly. A disease is a particular abnormal condition or a disorder of that affects part or all of an organisms. In the past few years, metabolic syndromes and other Complication under Endocrinology and medicine Fields are emerging very rapidly among the large amount of population. In order to aware the peoples, every year Endocrinology Conference is organised at global level by Conference Series llc. Conference series welcome to the world largest gathering in the 9th Annual Congress on Endocrine Disoders and Therapies will explore on Collaborative stratergies and Innovative Approaches to Fight Endocrine Disorders by bringing the international academics, practitioners and experts together in Chicago, USA from October 30-01, November 2017.

Market Analysis

Scope and Importance of Endocrinology

Endocrine 2017 Conference deals with the endocrinology and various different metabolic diseases and also deals with the endocrine glands. Endocrinology includes the study of hormones, the endocrine system, and their role in the physiology of the body. Endocrinology is a specialty of medicine which deals with the diagnosis and treatment of diseases related to hormones. Endocrinology deals with the human functions as the coordination of metabolism, respiration, reproduction, sensory perception, and movement.

The medical specialty of endocrinology involves the diagnostic evaluation of a wide variety of symptoms and variations and the long-term management of disorders of deficiency or excess of one or more hormones. The diagnosis and treatment of endocrine diseases are guided by laboratory tests to a greater extent than for most specialties. · Many diseases are investigated through ''excitation/stimulation'' or ''inhibition/suppression'' testing. This might involve injection with a stimulating agent to test the function of an endocrine organ. An endocrinologist needs extensive knowledge of clinical chemistry and biochemistry to understand the uses and limitations of the investigations.  

Some of the most common endocrine diseases include diabetes mellitus, hypothyroidism and the metabolic syndrome. Care of diabetes, obesity and other chronic diseases necessitates understanding the patient at the personal and social level as well as the molecular, and the physician–patient relationship can be an important therapeutic process. Apart from treating patients, many endocrinologists are involved in clinical science and medical research, teaching, and hospital management.

Conference series puts together the entire eminent endocrinologist across the globe to share their knowledge and views on the respective conference theme.

 

Why Chicago, USA? (American Region)

More than 29 million adults and children in the United States are living with complications caused by endocrine glands, and it’s estimated  that an additional 86 million Americans ages 20 years or older have metabolic syndromes like diabetes or obesity, putting them at increased risk of developing the disease. One of the Endocrinology Diseases i.e. Diabetes is the seventh leading cause of death in the United States. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

In order to prevent the people and make them aware regarding the metabolic diseases and other health complication caused like heart disease, blindness and kidney failure, an international conference is set up at Chicago, USA. Chicago, on Lake Michigan in Illinois, is among the largest cities and thirds most populous City in the U.S and fifth most populous city in North America.

Why to attend???

Endocrinology research involves the experts from different fields, physicians, nurse practitioners, physician’s assistants, nurses, dieticians, pharmacists, and health care professionals. This conference gives a broad platform to discuss and exchange their ideas and to understand the causes of this disease, major complications, and consequences and well enough to design rational therapies to defeat it. The young researchers and the student participants will gain the opportunity to grab the Best Poster Award by presenting their work as a poster presentation and Young Researcher Forum.

Target Audience:

9th Annual Congress on Endocrine Disorders and Therapies  includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, and pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof. The following are the data of audience:

Scientists      60%

Academia    30%

Others          10%

 

Overview of the Global endocrinology drugs market

Extensive market research carried out has shown that the global endocrinology market will grow steadily at a CAGR of more than 6% over the forecast period. An increase in the prevalence of hormone-related disorders such as diabetes, hypogonadism, hypothyroidism, and hyperthyroidism is one of the key factors driving the growth of this market over the forecast period. The prevalence of diabetes is on the rise owing to obesity, unhealthy diet, and lack of physical activity among individuals. According to many research studies, nearly 415 million individuals were affected by diabetes in 2015 and this number is likely to reach 642 million by 2040.  Moreover, with the growing prevalence of hypogonadism in men due to diabetes and heart or renal diseases, it is estimated that the intake of medications will increase. This increase in the intake of medications will propel the prospects for growth in this market during the next four years.

In this industry research report, the analysts have envisaged factors such as increasing awareness among people of thyroid disorders and diabetes to contribute to this market’s growth in the future. Members of the American Association of Clinical Endocrinologists are working toward increasing public awareness and educating the people about diseases caused by the increase or decrease in the release of hormones. For instance, November 14th is celebrated as the World Diabetes Day by over 200 member associations of the IDF. Similarly, in 2013, Eli Lilly collaborated with the American College of Endocrinology to educate individuals with diabetes about emergency planning by taking initiatives such as preparation of emergency kits. Also, Thyroid Awareness Month is organized in January every year, which is expected to spur the growth prospects for this market until the end of 2020.

Segmentation by application and analysis of the endocrinology drugs market

  • Thyroid hormone disorder drugs
  • Diabetes drugs
  • Human growth hormone
  • Testosterone replacement therapy

During 2016, the diabetes drugs segment dominated the endocrinology drugs market and accounted for more than 86% of the market share. The analysts have estimated factors such as the increasing number of individuals with diabetes and stringent guidelines for biosimilar drugs will propel this segment’s growth over the forecast period. Moreover, rising R&D activities and awareness programs will also significantly contribute to the growth of this segment until the end of 2020.

Geographical segmentation and analysis of the endocrinology drugs market

  • Americas
  • APAC
  • EMEA

During 2016, the Americas dominated the global endocrinology market and accounted for more than 58% of the market share in terms of revenue. The US was the largest revenue contributor to the region due to of the increasing prevalence of endocrine diseases like diabetes, thyroid disorders, and hypogonadism. Moreover, the high per capita income and well-developed research facilities will also aid in the growth of this market in the Americas.

Competitive landscape and key vendors

The global endocrinology drugs market is highly competitive owing to the presence of several small and large vendors. The market is open to new players and has a lot of opportunities for growth.  The competitive environment is expected to increase in due to the product extensions, new products, and new applications of the products and services provided. 

Key vendors in this market are –

  • Novo Nordisk
  • Sanofi
  • Merck
  • Eli Lily
  • AstraZeneca
  • AbbVie

Other prominent vendors analyzed in this market research report are Acerus Pharmaceuticals, Acrux DDS, Adocia, Æterna Zentaris, Akros Pharma, Allergan, Amgen, Antares Pharma, Ascendis Pharma, Astellas Pharma, Baxalta, Bayer HealthCare Pharmaceuticals, BHV Pharma, Biocon, Biodel, Boehringer Ingelheim, ChipScreen Biosciences, Clarus Therapeutics, ConjuChem, Critical Pharmaceuticals, CureDm, CymaBay Therapeutics, Daiichi Sankyo, Dance Biopharm, DiaMedica, Diamyd Therapeutics, Diasome Pharmaceuticals, DiaVacs, Dong-A ST, Eisai, Elcelyx Therapeutics, Endo Pharmaceuticals, Exsulin, Ferring Pharmaceuticals, Gan & Lee Pharmaceuticals, Genentech, Generex, Genexine, Genfit, GSK, HanAll BioPharma, Hanmi Pharmaceutical, Hua Medicine, ILTOO Pharma, Intarcia Therapeutics, InteKrin Therapeutics, Intrexon, Ionis Pharmaceuticals, Ipe, Islet Sciences, Janssen Pharmaceuticals, Japan Tobacco, Juniper Pharmaceuticals, Kadmon Corporation, Kamada, KinDex Pharmaceuticals, Kissei Pharmaceutical, Kotobuki, Lexicon Pharmaceuticals, LG Life Sciences, Ligand Pharmaceuticals, Lipocine, Living Cell Technologies, MacroGenics, MannKind, MedImmune, Melior Pharmaceuticals, Metabolic Solutions Development Company, MetP Pharma, Mitsubishi Tanabe Pharma, Mylan, NGM Biopharmaceuticals, Novartis, NuSirt Biopharma, OPKO Biologics, Oramed Pharmaceuticals, Osiris Therapeutics, Peptron, Perle Biosciences, Pfizer, PhaseBio Pharmaceuticals, Poxel, ProStrakan Group, REGiMMUNE, Repros Therapeutics, Roche, Sanwa Kagaku Kenkyusho, Sirona Biochem, Strongbridge Biopharma, Takeda Pharmaceuticals, TesoRx Pharma, Teva Pharmaceutical, Theracos, Theratechnologies, Toleranzia, Tolerion, Transition Therapeutics, VeroScience, Versartis, vTv Therapeutics, XBiotech, Xeris Pharmaceuticals, and XOMA.

Death Causes: According to the survey, it has been seen that the Complications caused due to endocrine glands and other metabolic causes death globally.

World:

 

USA

Out of 4 people in USA, 1 is affected from metabolic syndrome like obesity as well as diabetes. It has been surveyed that diabetes is listed in top 10 death causes.

 

Scenario of Health Complications

The following representation shows the world effected from the different types of health issues mainly caused by endocrines organs:  

 

Major Associations of Endocrinology around the Globe

  • Endocrine Society
  • American Association of Clinical Endocrinologists
  • The American Association of Endocrine Surgeons
  • Association of Program Directors in Endocrinology, Diabetes and Metabolism
  • Society for Endocrinology
  • Brazilian Society of Surgical Endocrinology
  • British Society for Pediatric Endocrinology and Diabetes
  • European Society of Endocrinology
  • International Society of Endocrinology
  • Pediatric Endocrine Society

Associations of Endocrinology in USA

  • American Association of Clinical Endocrinologists
  • Association of Program Directors in Endocrinology & Metabolism (APDEM)
  • Endocrine Fellows Foundation
  • Society for Endocrinology
  • The Endocrine Society
  • Union Endocrinology Associates
  • American Association of Endocrine Surgeon
  • American Thyroid Association
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Centres for Disease Control: Division of Diabetes Translation

 

Universities

The following are the top universities having the Endocrinology department:

  • Harvard University
  • University of Oxford
  • University of Cambridge
  • Johns Hopkins University
  • Stanford University
  • Yale University
  • University of California, Los Angeles (UCLA)
  • Imperial College London
  • University of Melbourne
  • Karolinska Institute

 

FUND ALLOTMENT

National Institute of Health (NIH) funding for research in the field of Endocrinology (year wise) globally: 

 

 

Table: Top NIH-funded U.S. Universities

SCHOOL AND INSTITUTES

 FUNDING

1

John Hopkins University

$454,227,609

2

University Of Pennsylvania

$379,821,590

3

University Of California- San Francisco

$363,648,042

4

University Of Washington

$325,046,213

5

University Of Pittsburgh

$319,064,044,

6

University Of Michigan At Ann Arbor

$308,603,579

7

University Of North Carolina

$307,141,539

8

Washington University

$304,176,206

9

University Of California, San Diego

$295,917,149

10

Duke University

$278,832,108

 

Statistics of member involved in diabetes:

About 63% members in this world are engaged in diabetes research and out of them 5% members of Dallas are involved.

 

 

 

 

Conference series welcomes you to the "9th Annual Congress on Endocrine Disorders and Therapies" to be held from October 30- November 1, 2017 at Chicago, Illinois USA. Endocrine 2017 will provide an opportunity for researchers to interact, share new results, show live demonstrations of their work, and discuss about innovative technologies and applications in many fields, including manufacturing techniques, drug administration techniques, drug discovery, drug delivery, product development etc

Theme of Endocrine 2017

“Collaborative Strategies and Innovative Approaches to fight Endocrine Disorders”